Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Adds Alison Herman to its Board of Directors

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

“Alison brings a proven ability to engage the philanthropic community of the Parkinson’s Foundation in funding research that helps improve the lives of people with the disease. I have known Alison for more than 30 years and am extremely impressed with her passion for our cause,” said John W. Kozyak, Esq., chairman of the board of the Parkinson’s Foundation. “We are proud to welcome Alison to our Board.”

Herman joined Southern Glazer’s in 2008 and currently focuses on regulatory and compliance matters in the 44 states where Southern Glazer’s operates. Prior to that, she served 14 years as attorney at Breier Seif Herman & Silverman, P.A., specializing in corporate acquisitions, retirement plans, distribution agreements, private foundations, tax and estate planning. Leveraging her experience, Herman has been instrumental in assisting the Parkinson’s Foundation Wines on the Bay event. Herman received a law degree from the University of Miami School of Law.

“It is an honor to join the Parkinson’s Foundation board and a great privilege to serve its community of those who are living with the disease,” Herman said. “Seeing a close family member affected by Parkinson’s gives me great resolve in the Foundation’s mission to make life better for people with Parkinson’s.”

A complete list of the Parkinson’s Foundation’s Board of Directors is available at www.parkinson.org/board.

###

About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression, as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

 

Tuesday, May 8, 2018
NPF and Global Kinetics Corporation Announce the Commencement of a Clinical Trial to Study Impact of Personal KinetiGraph Use in Routine Clinical Care of Patients with Parkinson's Disease
Wednesday, June 22, 2016

A multi-center, randomized controlled trial to assess whether the use of continuous objective measurement of changes in mobility in patients with Parkinson’s disease can improve physician treatment decisions and patient outcomes.

The National Parkinson Foundation Partners with Honor to Help the Home Care Company Deliver Personalized Care in the Home
Tuesday, June 21, 2016

The National Parkinson Foundation (NPF) and Honor home care announced today a collaborative partnership to bring personalized care in the home to people diagnosed with Parkinson’s.  Honor will license the NPF’s proprietary care guidance.

The National Parkinson Foundation Announces New Findings from Largest-Ever Parkinson’s Study of 8,000 Patients Worldwide
Monday, June 20, 2016

Latest Data Point To Improve Patient Care Through Precision Treatment

PDF Research Advocates Guide $16 Million in Parkinson’s Research Funding
Wednesday, June 15, 2016

Recently, two Parkinson’s Disease Foundation (PDF) volunteers helped guide $16 million in government funding for Parkinson’s disease (PD) research.

This spring, Sam Erwin, M.S., M.A., of West Des Moines, IA, and Paul Zimmet, D.D.S., of Reston, VA – both PDF Research Advocates, people living with PD and US Army Veterans – served as consumer reviewers of research funded by the US Department of Defense (DoD).

Parkinson's Disease Foundation Announces $4 Million in Research Investments to Solve, Treat and End Parkinson's Disease
Thursday, June 9, 2016

Research Funding for Early-Career Scientists Reflects Urgent Need for Better Therapies

Adaptive Athlete Announces 300 Skydives in 24 Hours
Wednesday, June 8, 2016

“300 Imperfect Jumps” Raises Funds for Parkinson’s Disease Research

NPF Celebrates the Life and the Legend of Muhammad Ali
Saturday, June 4, 2016

MIAMI — Today we mourn the loss and celebrate the life of Muhammad Ali, a longtime friend of the National Parkinson Foundation (NPF). Mr. Ali passed away at age 74 after being hospitalized for respiratory problems, a common complication in advanced Parkinson’s disease.

Parkinson’s Disease Foundation Marks Tenth Year of People with Parkinson’s Advisory Council
Tuesday, May 24, 2016

Patient Advisors Drive PDF Mission to Solve, Treat and End Parkinson’s

The Parkinson’s Disease Foundation® (PDF®) is pleased to mark the tenth year of its People with Parkinson’s Advisory Council and welcome five new members. Created in 2006, the council is made up of people living with Parkinson’s and care partners who drive PDF’s goals of ending the disease and improving the lives of those affected by it.

Fourth Annual Celebrate Spring Boston Raises $50,000 for Parkinson’s Disease Foundation
Tuesday, May 3, 2016

Boston Area Women Inspire Fellow Young Professionals to End Parkinson’s

FDA Approves Drug to Treat Parkinson’s Disease Psychosis
Friday, April 29, 2016

Today, the FDA approved Nuplazid (pimavanserin) as the first drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis, which affects up to 40% of people with Parkinson’s.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.